Wednesday 14 October 2015
gene therapy

Paying for gene therapy: Annuities the next big thing?

As US drugmakers face growing resistance to the high price of cutting-edge treatments, a handful of companies are working on a new payment model that rewards them for the long-term performance of their medicines. The effort, indus


First gene therapy drug sets record $1.4m price

The Western world's first gene therapy drug is set to go on sale in Germany with a 1.1 million euro ($1.4 million) price tag, a new record for a medicine to treat a rare disease. The sky-high cost of Glybera, from Dutch biotec


UK scientists tap gene therapy for blindness

Oxford scientists have set up a biotechnology company to develop the use of gene therapy in treating blindness, and the Wellcome Trust medical charity has invested 12 million pounds ($20 million) in the start-up. NightstaRx plans

 1 2 3 4 5 >  Last ›

calendarCalendar of Events